JP2009528824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009528824A5 JP2009528824A5 JP2008557434A JP2008557434A JP2009528824A5 JP 2009528824 A5 JP2009528824 A5 JP 2009528824A5 JP 2008557434 A JP2008557434 A JP 2008557434A JP 2008557434 A JP2008557434 A JP 2008557434A JP 2009528824 A5 JP2009528824 A5 JP 2009528824A5
- Authority
- JP
- Japan
- Prior art keywords
- modified
- amino acid
- coli
- aars
- translation system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 23
- 235000001014 amino acid Nutrition 0.000 claims 22
- 108020004566 Transfer RNA Proteins 0.000 claims 20
- 150000001413 amino acids Chemical class 0.000 claims 20
- 210000004027 cell Anatomy 0.000 claims 20
- 229920001184 polypeptide Polymers 0.000 claims 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 108091033319 polynucleotide Proteins 0.000 claims 10
- 239000002157 polynucleotide Substances 0.000 claims 10
- 102000040430 polynucleotide Human genes 0.000 claims 10
- 239000013598 vector Substances 0.000 claims 8
- 101000640990 Arabidopsis thaliana Tryptophan-tRNA ligase, chloroplastic/mitochondrial Proteins 0.000 claims 7
- 241000588724 Escherichia coli Species 0.000 claims 7
- 241000064099 Massilioclostridium coli Species 0.000 claims 7
- 108010003060 Methionine-tRNA ligase Proteins 0.000 claims 7
- 102100037206 Methionine-tRNA ligase, cytoplasmic Human genes 0.000 claims 7
- 102100034300 Tryptophan-tRNA ligase, cytoplasmic Human genes 0.000 claims 7
- -1 6-chloroindolyl Chemical group 0.000 claims 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 6
- 235000004279 alanine Nutrition 0.000 claims 6
- 101710146427 Probable tyrosine-tRNA ligase, cytoplasmic Proteins 0.000 claims 5
- 102100034298 Tyrosine-tRNA ligase, cytoplasmic Human genes 0.000 claims 5
- 101710107268 Tyrosine-tRNA ligase, mitochondrial Proteins 0.000 claims 5
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical compound CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 claims 4
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 claims 4
- 125000000539 amino acid group Chemical group 0.000 claims 3
- 210000003527 eukaryotic cell Anatomy 0.000 claims 3
- ROEBGGKWVJLWSP-MRVPVSSYSA-N (2r)-2-amino-3-(4-ethynyl-1h-pyrrol-3-yl)propanoic acid Chemical compound OC(=O)[C@H](N)CC1=CNC=C1C#C ROEBGGKWVJLWSP-MRVPVSSYSA-N 0.000 claims 2
- PEMUHKUIQHFMTH-QMMMGPOBSA-N (2s)-2-amino-3-(4-bromophenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(Br)C=C1 PEMUHKUIQHFMTH-QMMMGPOBSA-N 0.000 claims 2
- PPDNGMUGVMESGE-JTQLQIEISA-N (2s)-2-amino-3-(4-ethynylphenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(C#C)C=C1 PPDNGMUGVMESGE-JTQLQIEISA-N 0.000 claims 2
- JSXMFBNJRFXRCX-NSHDSACASA-N (2s)-2-amino-3-(4-prop-2-ynoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OCC#C)C=C1 JSXMFBNJRFXRCX-NSHDSACASA-N 0.000 claims 2
- FLHDTNWRXMTPMP-NSHDSACASA-N (2s)-2-amino-3-(5-ethynyl-1h-indol-3-yl)propanoic acid Chemical compound C1=C(C#C)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 FLHDTNWRXMTPMP-NSHDSACASA-N 0.000 claims 2
- UIKHEWRXMDFLKN-NSHDSACASA-N (2s)-2-amino-3-(6-ethynyl-1h-indol-3-yl)propanoic acid Chemical compound C#CC1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 UIKHEWRXMDFLKN-NSHDSACASA-N 0.000 claims 2
- HTFFMYRVHHNNBE-YFKPBYRVSA-N (2s)-2-amino-6-azidohexanoic acid Chemical compound OC(=O)[C@@H](N)CCCCN=[N+]=[N-] HTFFMYRVHHNNBE-YFKPBYRVSA-N 0.000 claims 2
- ZXSBHXZKWRIEIA-JTQLQIEISA-N (2s)-3-(4-acetylphenyl)-2-azaniumylpropanoate Chemical compound CC(=O)C1=CC=C(C[C@H](N)C(O)=O)C=C1 ZXSBHXZKWRIEIA-JTQLQIEISA-N 0.000 claims 2
- AKVBCGQVQXPRLD-UHFFFAOYSA-N 2-aminooctanoic acid Chemical compound CCCCCCC(N)C(O)=O AKVBCGQVQXPRLD-UHFFFAOYSA-N 0.000 claims 2
- OFYAYGJCPXRNBL-UHFFFAOYSA-N 2-azaniumyl-3-naphthalen-1-ylpropanoate Chemical compound C1=CC=C2C(CC(N)C(O)=O)=CC=CC2=C1 OFYAYGJCPXRNBL-UHFFFAOYSA-N 0.000 claims 2
- PZNQZSRPDOEBMS-QMMMGPOBSA-N 4-iodo-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(I)C=C1 PZNQZSRPDOEBMS-QMMMGPOBSA-N 0.000 claims 2
- 241001112695 Clostridiales Species 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 claims 2
- 241000238631 Hexapoda Species 0.000 claims 2
- 102000002265 Human Growth Hormone Human genes 0.000 claims 2
- 108010000521 Human Growth Hormone Proteins 0.000 claims 2
- 239000000854 Human Growth Hormone Substances 0.000 claims 2
- 102000003960 Ligases Human genes 0.000 claims 2
- 108090000364 Ligases Proteins 0.000 claims 2
- 241000589516 Pseudomonas Species 0.000 claims 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- 230000002538 fungal effect Effects 0.000 claims 2
- 238000010348 incorporation Methods 0.000 claims 2
- 230000003993 interaction Effects 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 210000005253 yeast cell Anatomy 0.000 claims 2
- JPZXHKDZASGCLU-LBPRGKRZSA-N β-(2-naphthyl)-alanine Chemical compound C1=CC=CC2=CC(C[C@H](N)C(O)=O)=CC=C21 JPZXHKDZASGCLU-LBPRGKRZSA-N 0.000 claims 2
- XHBJLKMBAFTWJD-JTQLQIEISA-N (2s)-2-amino-3-(3-ethynylphenyl)propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC(C#C)=C1 XHBJLKMBAFTWJD-JTQLQIEISA-N 0.000 claims 1
- NEMHIKRLROONTL-QMMMGPOBSA-N (2s)-2-azaniumyl-3-(4-azidophenyl)propanoate Chemical compound OC(=O)[C@@H](N)CC1=CC=C(N=[N+]=[N-])C=C1 NEMHIKRLROONTL-QMMMGPOBSA-N 0.000 claims 1
- NNWQLZWAZSJGLY-VKHMYHEASA-N (2s)-2-azaniumyl-4-azidobutanoate Chemical compound OC(=O)[C@@H](N)CCN=[N+]=[N-] NNWQLZWAZSJGLY-VKHMYHEASA-N 0.000 claims 1
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 claims 1
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 claims 1
- 108020005098 Anticodon Proteins 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- QWCKQJZIFLGMSD-VKHMYHEASA-N L-alpha-aminobutyric acid Chemical compound CC[C@H](N)C(O)=O QWCKQJZIFLGMSD-VKHMYHEASA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77937606P | 2006-03-03 | 2006-03-03 | |
| US77937506P | 2006-03-03 | 2006-03-03 | |
| US60/779,376 | 2006-03-03 | ||
| US60/779,375 | 2006-03-03 | ||
| PCT/US2007/005581 WO2007103307A2 (en) | 2006-03-03 | 2007-03-05 | Site-specific incorporation of amino acids into molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013095341A Division JP2013146274A (ja) | 2006-03-03 | 2013-04-30 | 分子へのアミノ酸の部位特異的な組み込み |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009528824A JP2009528824A (ja) | 2009-08-13 |
| JP2009528824A5 true JP2009528824A5 (https=) | 2011-04-14 |
| JP5808882B2 JP5808882B2 (ja) | 2015-11-10 |
Family
ID=38462077
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008557434A Active JP5808882B2 (ja) | 2006-03-03 | 2007-03-05 | 分子へのアミノ酸の部位特異的な組み込み |
| JP2013095341A Pending JP2013146274A (ja) | 2006-03-03 | 2013-04-30 | 分子へのアミノ酸の部位特異的な組み込み |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013095341A Pending JP2013146274A (ja) | 2006-03-03 | 2013-04-30 | 分子へのアミノ酸の部位特異的な組み込み |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8518666B2 (https=) |
| EP (1) | EP1999259B1 (https=) |
| JP (2) | JP5808882B2 (https=) |
| AU (2) | AU2007224019A1 (https=) |
| CA (1) | CA2644474A1 (https=) |
| DK (1) | DK1999259T3 (https=) |
| ES (1) | ES2504521T3 (https=) |
| PL (1) | PL1999259T3 (https=) |
| PT (1) | PT1999259E (https=) |
| SI (1) | SI1999259T1 (https=) |
| WO (1) | WO2007103307A2 (https=) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050287639A1 (en) | 2004-05-17 | 2005-12-29 | California Institute Of Technology | Methods of incorporating amino acid analogs into proteins |
| JP5313129B2 (ja) * | 2006-05-02 | 2013-10-09 | アロザイン， インコーポレイテッド | 非天然アミノ酸置換ポリペプチド |
| US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| WO2009059056A2 (en) * | 2007-11-02 | 2009-05-07 | The Scripps Research Institute | A genetically encoded boronate amino acid |
| JP5798489B2 (ja) | 2009-01-12 | 2015-10-21 | ストロ バイオファーマ， インコーポレイテッド | インビトロタンパク質合成システムを用いて非天然アミノ酸をタンパク質に選択的に導入するためのモノチャージシステム |
| EP2403864B1 (en) | 2009-02-27 | 2015-08-12 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
| AU2010327949A1 (en) * | 2009-12-11 | 2012-06-28 | Case Western Reserve University | Insulin analogues with chlorinated amino acids |
| CA2797093C (en) | 2010-04-26 | 2019-10-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| AU2011248521B2 (en) | 2010-04-27 | 2017-03-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl tRNA synthetases |
| EP2563381B1 (en) | 2010-04-27 | 2017-08-09 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| CN103097524B (zh) | 2010-04-28 | 2016-08-03 | Atyr医药公司 | 与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| EP2563383B1 (en) | 2010-04-29 | 2017-03-01 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| CA2797374C (en) | 2010-04-29 | 2021-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of asparaginyl trna synthetases |
| EP2566516B1 (en) | 2010-05-03 | 2019-07-03 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| ES2668207T3 (es) | 2010-05-03 | 2018-05-17 | Atyr Pharma, Inc. | Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de metionil-ARNt sintetasas |
| CN103096925A (zh) | 2010-05-03 | 2013-05-08 | Atyr医药公司 | 与精氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| AU2011248227B2 (en) | 2010-05-03 | 2016-12-01 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| JP6008844B2 (ja) | 2010-05-04 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | ｐ３８ＭＵＬＴＩ−ｔＲＮＡ合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| CN103096909A (zh) | 2010-05-04 | 2013-05-08 | Atyr医药公司 | 与谷氨酰-脯氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| EP2568996B1 (en) | 2010-05-14 | 2017-10-04 | aTyr Pharma, Inc. | Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| US9034598B2 (en) | 2010-05-17 | 2015-05-19 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| CN103096913B (zh) | 2010-05-27 | 2017-07-18 | Atyr 医药公司 | 与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| CA2800281C (en) | 2010-06-01 | 2021-01-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| AU2011289831C1 (en) | 2010-07-12 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| KR20130102534A (ko) | 2010-07-12 | 2013-09-17 | 에이티와이알 파마, 인코포레이티드 | 히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견 |
| US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| KR20180059575A (ko) | 2010-07-12 | 2018-06-04 | 에이티와이알 파마, 인코포레이티드 | 아스파르틸trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견 |
| CN103108650A (zh) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| MX349622B (es) | 2010-09-08 | 2017-08-07 | Halozyme Inc | Metodos para evaluar e identificar o evolucionar proteinas terapeuticas condicionalmente activas. |
| CN103118696B (zh) | 2010-10-06 | 2020-02-14 | Atyr 医药公司 | 与色氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物 |
| US20140140962A1 (en) * | 2011-04-29 | 2014-05-22 | The Research Foundation Of State University Of New York | Viruses modified with unnatural moieties and methods of use thereof |
| US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
| BR112014010666A2 (pt) * | 2011-11-03 | 2018-08-07 | Yeda Res & Dev | plantas transgênicas resistentes a aminoácidos não proteicos |
| WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
| WO2013086216A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Improved aspartyl-trna synthetases |
| TW202446781A (zh) | 2011-12-28 | 2024-12-01 | 日商中外製藥股份有限公司 | 胜肽化合物之製造方法 |
| CA2858613A1 (en) | 2011-12-29 | 2013-08-08 | Atyr Pharma, Inc. | Aspartyl-trna synthetase-fc conjugates |
| WO2013188635A2 (en) * | 2012-06-14 | 2013-12-19 | The Trustees Of The University Of Pennsylvania | Novel methods of identifying proteins via n-terminal tagging and selective pull-down |
| ES2708565T3 (es) | 2013-03-15 | 2019-04-10 | Atyr Pharma Inc | Conjugados de Fc-histidil-ARNt sintetasa |
| EP2979168A4 (en) * | 2013-03-29 | 2016-11-23 | Univ Washington Ct Commerciali | SYSTEMS, ALGORITHMS AND SOFTWARE FOR THE DESIGN OF A MOLECULAR INVERSION PROBE (MIP) |
| EP2876165A1 (en) | 2013-11-22 | 2015-05-27 | ACIB GmbH | Improved method for producing modifed target polypeptides |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| EP4166664A1 (en) | 2015-03-13 | 2023-04-19 | Chugai Seiyaku Kabushiki Kaisha | Modified aminoacyl-trna synthetase and use thereof |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| GB201600512D0 (en) * | 2016-01-12 | 2016-02-24 | Univ York | Recombinant protein production |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| JP7187323B2 (ja) | 2017-01-31 | 2022-12-12 | 中外製薬株式会社 | 無細胞翻訳系におけるペプチドの合成方法 |
| PE20191716A1 (es) | 2017-02-08 | 2019-12-05 | Bristol Myers Squibb Co | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos |
| JP6917050B2 (ja) * | 2017-03-06 | 2021-08-11 | 学校法人早稲田大学 | 最適特性を有する非天然型タンパク質の製造方法 |
| CA3060514A1 (en) | 2017-04-20 | 2018-10-25 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
| KR20250007021A (ko) | 2017-06-09 | 2025-01-13 | 추가이 세이야쿠 가부시키가이샤 | N-치환 아미노산을 포함하는 펩타이드의 합성 방법 |
| US11442067B2 (en) * | 2017-07-25 | 2022-09-13 | Biocon Limited | Peptide mapping method for sequence identification of insulin and insulin analogues |
| WO2019117274A1 (ja) | 2017-12-15 | 2019-06-20 | 中外製薬株式会社 | ペプチドの製造方法、及び塩基の処理方法 |
| CN108588040B (zh) * | 2018-06-08 | 2021-06-15 | 中国医学科学院病原生物学研究所 | 重组MtMetRS、其晶体及它们在制备抗结核药物中的应用 |
| CA3111576A1 (en) | 2018-09-11 | 2020-03-19 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and their uses |
| EP3878836B1 (en) | 2018-11-07 | 2025-07-23 | Chugai Seiyaku Kabushiki Kaisha | O-substituted serine derivative production method |
| WO2020111238A1 (ja) | 2018-11-30 | 2020-06-04 | 中外製薬株式会社 | ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法 |
| EP3904568A4 (en) | 2018-12-26 | 2024-03-20 | Chugai Seiyaku Kabushiki Kaisha | Mutated trna for codon expansion |
| EP3938046A1 (en) * | 2019-03-13 | 2022-01-19 | St. Jude Children's Research Hospital | Vaccine compositions and methods for reducing transmission of streptococcus pneumoniae |
| EP3939962A4 (en) | 2019-03-15 | 2022-12-28 | Chugai Seiyaku Kabushiki Kaisha | PROCESS FOR PREPARING AN AROMATIC AMINO ACID DERIVATIVE |
| BR112022007535A2 (pt) | 2019-11-07 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Composto peptídico cíclico tendo ação inibitória de kras |
| CN114641569A (zh) | 2019-12-26 | 2022-06-17 | 中外制药株式会社 | 翻译用组合物及肽的制备方法 |
| GB2610490A (en) | 2020-03-31 | 2023-03-08 | Protomer Tech Inc | Conjugates for selective responsiveness to vicinal diols |
| AR122020A1 (es) | 2020-05-05 | 2022-08-03 | Genentech Inc | Sistemas y métodos para la conjugación específica de sitio de proteínas mediada por tirosinasa |
| JPWO2021261577A1 (https=) | 2020-06-25 | 2021-12-30 | ||
| PE20231309A1 (es) * | 2020-10-17 | 2023-08-24 | Sun Pharmaceutical Ind Ltd | Agonistas duales glp-1/gip |
| IL302775A (en) | 2020-11-19 | 2023-07-01 | Protomer Tech Inc | Aromatic boron-containing compounds and insulin analogs |
| US20240384267A1 (en) | 2021-09-20 | 2024-11-21 | The Broad Institute, Inc. | Compositions and methods for multiplex decoding of quadruplet codons |
| IL317049A (en) | 2022-05-18 | 2025-01-01 | Protomer Tech Inc | Aromatic boron-containing compounds and related insulin analogs |
| WO2023250446A2 (en) * | 2022-06-22 | 2023-12-28 | The University Of Chicago | ENGINEERED tRNA AND METHODS OF USE |
| CN116376851A (zh) * | 2022-08-25 | 2023-07-04 | 凯莱英医药集团（天津）股份有限公司 | 氨酰tRNA合酶突变体及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0576592B1 (en) | 1991-03-18 | 2000-05-31 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
| DK0974111T3 (da) | 1997-04-11 | 2003-04-22 | California Inst Of Techn | Apparat og metode til automatiseret design af proteiner |
| US7449443B2 (en) | 2000-03-23 | 2008-11-11 | California Institute Of Technology | Method for stabilization of proteins using non-natural amino acids |
| WO2002085923A2 (en) | 2001-04-19 | 2002-10-31 | The Scripps Research Institute | In vivo incorporation of unnatural amino acids |
| WO2003073238A2 (en) * | 2002-02-27 | 2003-09-04 | California Institute Of Technology | Computational method for designing enzymes for incorporation of amino acid analogs into proteins |
| MXPA05003978A (es) | 2002-10-16 | 2005-06-22 | Scripps Research Inst | Sintesis de glicoproteinas. |
| BRPI0507169A (pt) | 2004-02-02 | 2007-06-26 | Ambrx Inc | polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos |
| US20050260711A1 (en) | 2004-03-30 | 2005-11-24 | Deepshikha Datta | Modulating pH-sensitive binding using non-natural amino acids |
| US20050287639A1 (en) | 2004-05-17 | 2005-12-29 | California Institute Of Technology | Methods of incorporating amino acid analogs into proteins |
| WO2006091231A2 (en) | 2004-07-21 | 2006-08-31 | Ambrx, Inc. | Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| US20090181858A1 (en) | 2004-09-21 | 2009-07-16 | The Scripps Research Institute | Adding photoregulated amino acids to the genetic code |
| JP2008516637A (ja) | 2004-10-20 | 2008-05-22 | ザ スクリップス リサーチ インスティテュート | 真正細菌へのｎ−アセチルガラクトサミンアミノ酸のインビボ部位特異的組込み |
| EP2399893B1 (en) | 2004-12-22 | 2018-08-15 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| EP1836298B1 (en) | 2004-12-22 | 2012-01-18 | Ambrx, Inc. | COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF |
| EP1891092A4 (en) | 2005-06-03 | 2011-12-21 | Ambrx Inc | INSTALLATION OF NATURALLY CODED AMINO ACIDS IN PROTEINS |
| AU2005335491B2 (en) | 2005-08-18 | 2010-11-25 | Ambrx, Inc. | Compositions of tRNA and uses thereof |
| WO2007070659A2 (en) | 2005-12-14 | 2007-06-21 | Ambrx, Inc. | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| AU2007215566A1 (en) | 2006-01-19 | 2007-08-23 | Ambrx, Inc. | Non-natural amino acid polypeptides having modulated immunogenicity |
-
2007
- 2007-03-05 AU AU2007224019A patent/AU2007224019A1/en not_active Abandoned
- 2007-03-05 EP EP07752295.1A patent/EP1999259B1/en not_active Not-in-force
- 2007-03-05 WO PCT/US2007/005581 patent/WO2007103307A2/en not_active Ceased
- 2007-03-05 CA CA002644474A patent/CA2644474A1/en not_active Abandoned
- 2007-03-05 JP JP2008557434A patent/JP5808882B2/ja active Active
- 2007-03-05 US US11/682,272 patent/US8518666B2/en not_active Expired - Fee Related
- 2007-03-05 SI SI200731519T patent/SI1999259T1/sl unknown
- 2007-03-05 ES ES07752295.1T patent/ES2504521T3/es active Active
- 2007-03-05 PL PL07752295T patent/PL1999259T3/pl unknown
- 2007-03-05 DK DK07752295.1T patent/DK1999259T3/da active
- 2007-03-05 PT PT77522951T patent/PT1999259E/pt unknown
-
2013
- 2013-04-30 JP JP2013095341A patent/JP2013146274A/ja active Pending
- 2013-08-16 US US13/969,368 patent/US8980581B2/en active Active
-
2014
- 2014-05-20 AU AU2014202733A patent/AU2014202733A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009528824A5 (https=) | ||
| WO2007103307B1 (en) | Site-specific incorporation of amino acids into molecules | |
| Flamholz et al. | Functional reconstitution of a bacterial CO2 concentrating mechanism in Escherichia coli | |
| JP2023116605A (ja) | 改変アミノアシルｔＲＮＡ合成酵素およびその用途 | |
| CN110551700B (zh) | Adh蛋白家族突变体及其应用 | |
| US11673921B2 (en) | Cell-free protein synthesis platform derived from cellular extracts of Vibrio natriegens | |
| JP2010506591A5 (https=) | ||
| JP2008513040A5 (https=) | ||
| CN115175994A (zh) | 组氨酸、嘌呤途径代谢物和质粒dna的增强的产生 | |
| CN107002074A (zh) | 活性型突变酶的制造方法及新型活性型突变酶、以及可溶性化突变蛋白的制造方法 | |
| JP2011500077A (ja) | 方法及び組成物 | |
| CN114450403A (zh) | 用于在枫糖尿症(msud)的治疗中使用的酶的生物合成 | |
| JPWO2020116331A1 (ja) | 改変型菊酸エステラーゼ | |
| EP4232571A1 (en) | Novel variants of endonuclease v and uses thereof | |
| Sawaya et al. | Mutational analysis of the guanylyltransferase component of mammalian mRNA capping enzyme | |
| CN121249628B (zh) | 一种PhPepD突变体及其在发酵生产L-肌肽中的应用 | |
| US12509665B2 (en) | Thioredoxin mutant, preparation method thereof, and application thereof in production of recombinant fusion protein | |
| JP6803047B2 (ja) | ジホスホメバロン酸デカルボキシラーゼ変異体、及びそれを用いたオレフィン化合物の製造方法 | |
| JP5821843B2 (ja) | ジアホラーゼ活性を有するタンパク質 | |
| US20250043267A1 (en) | Engineered bacterial tyrosyl-trna synthetase mutants for incorporating unnatural amino acids into proteins | |
| CN111575251B (zh) | 一种用于达托霉素生物合成的dptC1突变体的构建 | |
| JP7054092B2 (ja) | ジホスホメバロン酸デカルボキシラーゼ変異体、及びそれを用いたオレフィン化合物の製造方法 | |
| JP6995315B2 (ja) | ジホスホメバロン酸デカルボキシラーゼ変異体、及びそれを用いたオレフィン化合物の製造方法 | |
| JP2012120506A (ja) | Ａｍｖ逆転写酵素遺伝子、該遺伝子によりコードされるａｍｖ逆転写酵素及び該遺伝子を用いるａｍｖ逆転写酵素の製造方法 | |
| JP2011239686A (ja) | ペプチド及びペプチド誘導体の製造方法 |